Intas Bio Pharmaceuticals Limited

Intas is a leading vertically integrated global pharmaceutical formulation development manufacturing and marketing company headquartered in India. Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing R & D Biotechnology and global operations over three decades. As of 31st of March 2013 Intas has grown to be a $650 million* organization with a revenue growth over 30% CAGR over the last 5 years and a profit growth of 50% CAGR over the same period. Intas is now ranked as the 12th largest pharmaceutical company in the domestic market (as per IMS Health India Secondary Stockist Audit (SSA) February 2013). In the domestic market Intas is the 4th largest corporate in Indian Chronic Pharma Market with a market share of more than 5%. It also has presence in central nervous system (CNS) cardiovascular system (CVS) diabetology gastroenterology and pain management. Recently Intas has extended its presence into other therapy areas such as gynecology infertility and respiratory care. Besides rapidly growing domestic prominence Intas is also present in more than 70 countries worldwide with robust sales marketing and distribution infrastructure in markets like North America Europe Central & Latin America Africa Australia New Zealand Asia - Pacific as well as CIS and MENA countries.